Cargando…
Correction to: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo efects of Lenabasum(TM)
Autores principales: | Maddukuri, Spandana, Patel, Jay, Diaz, De Anna, Chen, Kristen L., Wysocka, Maria, Bax, Christina, Li, Yubin, Ravishankar, Adarsh, Grinnell, Madison, Zeidi, Majid, Reddy, Nithin, Concha, Josef Symon S., Bashir, Muhammad M., Okawa, Joyce, White, Barbara, Werth, Victoria P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915490/ https://www.ncbi.nlm.nih.gov/pubmed/35277198 http://dx.doi.org/10.1186/s13075-022-02758-1 |
Ejemplares similares
-
Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of Lenabasum(TM)
por: Maddukuri, Spandana, et al.
Publicado: (2022) -
Environmental triggers of dermatomyositis: a narrative review
por: Bax, Christina E., et al.
Publicado: (2021) -
Herbal supplement Spirulina stimulates inflammatory cytokine production in patients with dermatomyositis in vitro
por: Bax, Christina E., et al.
Publicado: (2023) -
Plasma-derived DNA containing-extracellular vesicles induce STING-mediated proinflammatory responses in dermatomyositis
por: Li, Yubin, et al.
Publicado: (2021) -
278 Photo validation study using cutaneous dermatomyositis disease area and severity index in dermatomyositis patients
por: Grinnell, M., et al.
Publicado: (2022)